Hinge Health (NYSE:HNGE) President Sells $3,106,620.00 in Stock

Hinge Health Inc. (NYSE:HNGE) President James Pursley sold 33,000 shares of the firm’s stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $94.14, for a total value of $3,106,620.00. Following the transaction, the president owned 666,909 shares in the company, valued at approximately $62,782,813.26. This trade represents a 4.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Pursley also recently made the following trade(s):

• On Friday, August 21st, James Pursley sold 33,000 shares of Hinge Health stock. The shares were sold at an average price of $88.05, for a total value of $2,905,650.00.

Hinge Health Price Performance

Shares of NYSE:HNGE opened at $95.35 on Friday. The company has a market capitalization of $7.69 billion, a price-to-earnings ratio of 74.49 and a beta of 1.38. The firm’s 50 day simple moving average is $87.26 and its 200 day simple moving average is $67.50. Hinge Health Inc. has a fifty-two week low of $30.08 and a fifty-two week high of $96.66.

Hinge Health (NYSE:HNGE) last issued its earnings results on Tuesday, August 4th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.28 by $0.31. The firm had revenue of $212.82 million during the quarter. Hinge Health had a net margin of 15.15% and a return on equity of 51.60%. The firm’s revenue for the quarter was up 53.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.59 EPS. Equities research analysts expect that Hinge Health Inc. will post 1.25 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on HNGE shares. Stifel Nicolaus increased their target price on Hinge Health from $96.00 to $115.00 and gave the stock a “buy” rating in a research note on Tuesday, September 8th. Weiss Ratings raised shares of Hinge Health from a “sell (d-)” rating to a “hold (c)” rating in a research note on Tuesday. Citizens Jmp upped their price target on shares of Hinge Health from $96.00 to $107.00 and gave the company a “market outperform” rating in a report on Wednesday, August 5th. Morgan Stanley increased their price objective on shares of Hinge Health from $72.00 to $108.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Finally, Barclays boosted their price objective on shares of Hinge Health from $97.00 to $100.00 and gave the company an “overweight” rating in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $103.71.

Hedge Funds Weigh In On Hinge Health

A number of large investors have recently bought and sold shares of the company. 11.2 Capital Management LLC bought a new position in shares of Hinge Health in the second quarter valued at $204,566,531. BIT Capital GmbH raised its position in Hinge Health by 79.3% during the fourth quarter. BIT Capital GmbH now owns 3,316,101 shares of the company’s stock worth $154,033,000 after acquiring an additional 1,466,577 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its position in Hinge Health by 225.7% during the first quarter. Arrowstreet Capital Limited Partnership now owns 1,163,187 shares of the company’s stock worth $44,852,000 after acquiring an additional 806,007 shares in the last quarter. Wellington Management Group LLP lifted its stake in Hinge Health by 169.7% in the second quarter. Wellington Management Group LLP now owns 1,205,584 shares of the company’s stock valued at $100,063,000 after acquiring an additional 758,594 shares during the last quarter. Finally, BNP Paribas Financial Markets grew its position in shares of Hinge Health by 162.7% in the 4th quarter. BNP Paribas Financial Markets now owns 727,672 shares of the company’s stock valued at $33,800,000 after acquiring an additional 450,643 shares during the period.

Hinge Health Company Profile

Hinge Health, Inc is a digital health company focused on musculoskeletal care. The company provides virtual programs designed to help people manage and improve conditions affecting the back, joints and other areas of the musculoskeletal system, with the goal of supporting conservative care and reducing the need for more invasive treatment.

Its platform combines personalized exercise therapy, digital tools, clinical guidance and behavioral support. Depending on the program, members may use the Hinge Health mobile application, wearable motion sensors and remote care from physical therapists, health coaches and other clinicians.